PTEN expression in endometrial hyperplasia and risk of cancer: a systematic review and meta-analysis Antonio RaffoneAntonio TravaglinoFulvio Zullo Review 26 March 2019 Pages: 1511 - 1524
The security of radical trachelectomy in the treatment of IA–IIA cervical carcinoma requires further evaluation: updated meta-analysis and trial sequential analysis Ying FengZihan ZhangZhenyu Zhang Review 22 April 2019 Pages: 1525 - 1536
The immature platelet fraction in hypertensive disease during pregnancy Ulrike BernsteinThorsten KaiserAlexander Jank Maternal-Fetal Medicine 27 February 2019 Pages: 1537 - 1543
Risk-adapted management for vasa praevia: a retrospective study about individualized timing of caesarean section Gülen Yerlikaya-SchattenKinga M. ChalubinskiJohannes Ott Maternal-Fetal Medicine Open access 26 March 2019 Pages: 1545 - 1550
Wnt signaling pathway in early- and late-onset preeclampsia: evaluation with Dickkopf-1 and R-Spondin-3 glycoproteins Ahter Tanay TayyarResul KarakusAhmet Tayyar Maternal-Fetal Medicine 23 March 2019 Pages: 1551 - 1556
Pilot study: placental biomarker predictive capability (sFlt-1, PlGF and their ratio) of postpartum maternal outcome Amr HamzaCh. GerlingerM. Kasoha Maternal-Fetal Medicine 05 April 2019 Pages: 1557 - 1566
Calprotectin in pregnancy and pregnancy-associated diseases: a systematic review and prospective cohort study Günther A. RezniczekClaudia FörsterClemens B. Tempfer Maternal-Fetal Medicine 05 April 2019 Pages: 1567 - 1577
An observation study of the emergency intervention in placenta accreta spectrum Yan WangLin ZengYangyu Zhao Maternal-Fetal Medicine 05 April 2019 Pages: 1579 - 1586
Comparison of two “a priori” risk assessment algorithms for preeclampsia in Italy: a prospective multicenter study Daniela Di MartinoBianca MasturzoAntonio Farina Maternal-Fetal Medicine 05 April 2019 Pages: 1587 - 1596
Disease activity and thromboembolic events in women with systemic lupus erythematosus with and without anti-phospholipid syndrome: users of the 52-mg levonorgestrel-releasing intrauterine system Rafaella C. RebeloEstephania PignatonArlete Fernandes General Gynecology 02 April 2019 Pages: 1597 - 1605
Current practice and physicians’ opinion about preoperative hair removal as a part of ERAS pathway implementation in gynecology and gynecology–oncology: a NOGGO-AGO survey of 148 gynecological departments in Germany Helmut PlettEnzo RicciardiJalid Sehouli General Gynecology 05 April 2019 Pages: 1607 - 1618
Laparoscopic excision of deeply infiltrating endometriosis: a prospective observational study assessing perioperative complications in 244 patients Shaheen KhazaliAtefeh GorginVasilis Minas General Gynecology 05 April 2019 Pages: 1619 - 1626
Curcumin induces apoptotic cell death and protective autophagy by inhibiting AKT/mTOR/p70S6K pathway in human ovarian cancer cells Li-dong LiuYing-xin PangPei-shu Liu Gynecologic Oncology 21 April 2019 Pages: 1627 - 1639
Efficacy of pegylated liposomal doxorubicin maintenance therapy in platinum-sensitive recurrent epithelial ovarian cancer: a retrospective study Erin A. BlakeChrystal A. BradleyKoji Matsuo Gynecologic Oncology 01 March 2019 Pages: 1641 - 1649
Utero-ovarian preservation and overall survival of young women with early-stage borderline ovarian tumors Rachel S. MandelbaumErin A. BlakeKoji Matsuo Gynecologic Oncology 28 March 2019 Pages: 1651 - 1658
Prevalence of oral HPV infection in cervical HPV positive women and their sexual partners T. K. EggersmannK. SharafJ. K. S. Gallwas Gynecologic Oncology 05 April 2019 Pages: 1659 - 1665
Risk factors for failure of sentinel lymph node mapping using indocyanine green/near-infrared fluorescent imaging in endometrial cancer Salih TaşkınMustafa Erkan SarıFırat Ortaç Gynecologic Oncology 29 March 2019 Pages: 1667 - 1672
Molecular expression characteristics confirm the malignancy concealed by morphological alterations in endometrial cancer after fertility-preserving treatment Ting Wen Yi HuLei LiZheng Yu Li Gynecologic Oncology 05 April 2019 Pages: 1673 - 1682
Tumor-targeting Salmonella typhimurium A1-R overcomes nab-paclitaxel resistance in a cervical cancer PDOX mouse model Kentaro MiyakeTakuya MurataRobert M. Hoffman Gynecologic Oncology 05 April 2019 Pages: 1683 - 1690
A new approach to prevent ischemia/reperfusion injury in a rat model: remote ischemic conditioning Mehmet SipahiMucahit GunaydinCanberk Tomruk Gynecologic Oncology 12 April 2019 Pages: 1691 - 1699
The myo-inositol effect on the oocyte quality and fertilization rate among women with polycystic ovary syndrome undergoing assisted reproductive technology cycles: a randomized clinical trial Azadeh Akbari SeneAzam TabatabaieFatemehsadat Amjadi Gynecologic Endocrinology and Reproductive Medicine 27 March 2019 Pages: 1701 - 1707
Screening for blood born viruses in assisted reproduction: is annual testing necessary? Eran GoldYossi MizrachiAriel Weissman Gynecologic Endocrinology and Reproductive Medicine 14 March 2019 Pages: 1709 - 1713
Novel circular RNA expression in the cumulus cells of patients with polycystic ovary syndrome Zhi MaHuishan ZhaoCuifang Hao Gynecologic Endocrinology and Reproductive Medicine 02 April 2019 Pages: 1715 - 1725
Endometrial human chorionic gonadotropin (hCG) expression is a marker for adequate secretory transformation of the endometrium Sindy SchugAnja BaunackeHenry Alexander Gynecologic Endocrinology and Reproductive Medicine 06 April 2019 Pages: 1727 - 1736
Blockade pf CD73/adenosine axis improves the therapeutic efficacy of docetaxel in epithelial ovarian cancer Hongmei LiMeihua LvXia Li Images in Obstetrics and Gynecology 02 April 2019 Pages: 1737 - 1746
Risk factors, microbiology, and management of infected lymphocyst after lymphadenectomy for gynecologic malignancies: letter to the editor Ibrahim A. AbdelazimGulmira ZhurabekovaBakyt Karimova Correspondence 31 January 2019 Pages: 1747 - 1748
Reply to comments on “Risk factors, microbiology and management of infected lymphocyst after lymphadenectomy for gynecologic malignancies” Xuegong MaYingmei WangFengxia Xue Correspondence 06 April 2019 Pages: 1749 - 1750
Modified hysterectomy for placenta increta and percreta: modifications of what? Shigeki MatsubaraHironori TakahashiYuji Takei Correspondence 11 March 2019 Pages: 1751 - 1752
Reply to the comments on "Modified hysterectomy for placenta increta and percreta: modifications of what?" Ahmed M. HusseinAhmed Kamel Correspondence 20 March 2019 Pages: 1753 - 1755
